Maxcyte Inc (MXCT) Live Share Price, Invest From India

Maxcyte Inc Stock Performance

as on March 28, 2026 at 6:59 am IST

Day's Low
Day's High
$0.66
Day's Price Range
$0.72
$0.68
2.94%
Downside
5.88%
Upside
52 Week's Low
52 Week's High
$0.64
52-Week Price Range
$2.96
$0.68
5.38%
Downside
334.56%
Upside

Maxcyte Inc share price movements today

Previous Close: $0.72
Open: $0.70
Volume: 1.3M
Day's Low - High: $0.66 - $0.72
52 Week Low - High: $0.64 - $2.96

Maxcyte Inc Historical Returns

1 Month Return: -15.74 %
3 Month Return: -57.54 %
1 Year Return: -74.96 %
3 Year Return: -83.25 %
5 Year Return: 0 %

Maxcyte Inc Stock Fundamentals & Key Indicators

Check Maxcyte Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$76.6M

EPS (TTM)

-0.2896

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-40.2M

Revenue (TTM)

33.0M

Profit Margin

-135.14%

Return On Equity TTM

-23.63%

Maxcyte Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Maxcyte Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Maxcyte Inc	BUY	$76.6M	NA	NA	-135.14%
Boston Scientific Corp.	BUY	$104.3B	80.98%	36.17	14.44%
Stryker Corporation	BUY	$127.4B	35.88%	39.7	12.92%
Medtronic Plc	BUY	$112.6B	-26.5%	24.49	13.00%
Abbott Laboratories	BUY	$181.7B	-14.81%	28.11	14.72%

See all

Stock Returns calculator for Maxcyte Inc Stock including INR - Dollar returns

The Maxcyte Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Maxcyte Inc investment value today

Current value as on today

₹35,417

Returns

₹64,583

(-64.58%)

Returns from Maxcyte Inc Stock

₹75,092 (-75.09%)

Dollar Returns*

₹10,509 (+10.51%)

Analyst Recommendation on Maxcyte Inc Stock

Based on 13 analysts

BUY

92.31%

Buy

7.69%

Hold

0.00%

Sell

Based on 13 analysts, 92.31% of analysts recommend a 'BUY' rating for Maxcyte Inc. Average target price of $4.05

Maxcyte Inc Share Price Target

Get share price movements and forecasts by analysts on Maxcyte Inc.

What analysts predicted

83.21%UPSIDE

Target Price

$4.05

Current Price

$0.68

Analyzed by

13 Analysts

Target

$4.05

Maxcyte Inc target price $4.05, a slight upside of 83.21% compared to current price of $0.68. According to 13 analysts rating.

Maxcyte Inc Stock’s Investor Sentiment and Interest

Search interest for Maxcyte Inc Stock has increased by 68% in the last 30 days, reflecting an upward trend in search activity.

Time period: February 26, 2026 to March 28, 2026

Change:68% versus previous 30 day period

Maxcyte Inc Quarterly Profit & Loss

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Total Revenue	8	15	11	10	8	8	10	8	6	7
Gross Profit	7	14	9	8	6	6	8	6	6	4
Operating Income	-13	-8	-12	-11	-14	-12	-12	-14	-10	-8
EBITDA	-12	-6	-11	-10	-12	-11	-11	-12	-11	-6
Interest Expense	-	2	-	-	-	-	-	-	-	-
Depreciation	1	1	1	1	1	1	1	1	1	-
Income Before Tax	-11	-5	-9	-9	-11	-10	-10	-12	-12	-9
Income Tax Expense	1,904	0	1	-	-	-	-	-	-	-
Net Income	-11	-5	-9	-9	-11	-10	-10	-12	-12	-9
Net Profit Margin	-140.58%	-33.69%	-83.99%	-89.89%	-141.56%	-121.90%	-98.76%	-145.26%	-181.81%	-131.45%

Maxcyte Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	12	13	16	21	26	33	44	41	38	33
Gross Profit	10	12	14	19	23	30	39	36	31	26
Operating Income	-2	-9	-8	-12	-11	-18	-27	-48	-51	-45
EBITDA	-2	-9	-7	-11	-9	-16	-24	-44	-46	-40
Interest Expense	0	0	0	0	0	1	0	-	-	-
Depreciation	-	0	0	0	1	1	2	3	4	-
Income Before Tax	-3	-9	-8	-12	-11	-19	-23	-37	-41	-44
Income Tax Expense	0	-	0	0	0	1	-3	4	-	-
Net Income	-3	-9	-8	-12	-11	-19	-23	-37	-41	-44
Net Profit Margin	-27.27%	-70.91%	-53.21%	-59.64%	-45.15%	-56.30%	-53.25%	-91.85%	-106.29%	-135.14%

Maxcyte Inc Quarterly Cash Flow

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Net Income	-5	-9	-9	-11	-10	-10	-12	-12	-9
Operating Cash Flow	0	-10	-4	-4	-7	-14	-9	-7	-2
Investing Cash Flow	-4	-14	19	3	-1	9	1	5	9
Financing Cash Flow	0	0	0	0	0	0	0	0	0
Change in Cash	-2	-24	15	0	-9	-4	-8	-2	7

Maxcyte Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-9	-8	-12	-11	-19	-23	-37	-41	-44
Operating Cash Flow	-9	-10	-8	-8	-10	-14	-21	-27	-34
Investing Cash Flow	0	-3	0	-16	-195	-24	54	6	25
Financing Cash Flow	23	0	12	28	234	2	2	2	0
Change in Cash	13	-14	3	3	29	-36	35	-18	-7

Global Institutional Holdings in Maxcyte Inc

Funds	Holdings
BNP Paribas Asset Management (Former AXA IM)	2.6%
Rice Hall James & Associates, LLC	0.39%
Northern Trust Corp	0.74%
Mudita Advisors LLP	3.16%
D. E. Shaw & Co LP	0.62%

See all

Insights on Maxcyte Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, 6.82M → 7.3M (in $), with an average increase of 6.5% per quarter
POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, -12.41M → -9.59M (in $), with an average increase of 29.4% per quarter
NO EFFECT
Against Peers
In the last 1 year, Edwards Lifesciences Corp. has given 11.9% return, outperforming this stock by 86.9%
NO EFFECT
Against Peers
In the last 3 years, Maxcyte Inc has experienced a drawdown of -83.2%, however Boston Scientific Corp. resisted the overall trend and outperformed by 81.8%
NEGATIVE IMPACT
Price Dip
In the last 3 months, MXCT stock has moved down by -57.5%

About Maxcyte Inc

MaxCyte is a leading commercial cell-engineering company focused on providing enabling platform technologies to advance innovative cell-based research as well as next-generation cell therapeutic discovery, development and commercialization.

Organisation	Maxcyte Inc
Headquarters	9713 Key West Avenue, Rockville, MD, United States, 20850
Industry	Healthcare
CEO	Mr. Maher Masoud
E-voting on shares	Click here to vote

Key Management of Maxcyte Inc

Name	Title
Mr. Douglas J. Swirsky CFA, CPA	Chief Financial Officer
Mr. Jay Gelfman	Senior Vice President of Operations
Mr. Jack Horgan	Senior Vice President of Corporate Development
Ms. Ana-Paula Martins Fernandes	Senior Vice President of Global Sales
Ms. Jill Mayer	Senior Vice President of Human Resources
Mr. Maher Masoud	President, CEO & Executive Director

FAQs

What is Maxcyte Inc share price today?

Maxcyte Inc share price today is $0.68 as on March 28, 2026 at 1:29 am IST at the close of the market. Maxcyte Inc share today touched a day high of $0.72 and a low of $0.66.

What is the 52 week high and 52 week low for Maxcyte Inc share?

Maxcyte Inc share touched a 52 week high of $2.96 on April 28, 2025 and a 52 week low of $0.64 on February 17, 2026. Maxcyte Inc stock price today i.e. March 28, 2026 at 1:29 am IST is closed at $0.68,which is 76.99% down from its 52 week high and 5.69% up from its 52 week low.

What is Maxcyte Inc's market capitalisation today?

Maxcyte Inc market capitalisation is $0.00T as on March 28, 2026 at 1:29 am IST.

How to invest in Maxcyte Inc Stock (MXCT) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Maxcyte Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Maxcyte Inc Shares that will get you 2.2059 shares as per Maxcyte Inc share price of $0.68 per share as on March 28, 2026 at 1:29 am IST.

What is the minimum amount required to buy Maxcyte Inc Stock (MXCT) from India?

Indian investors can start investing in Maxcyte Inc (MXCT) shares with as little as ₹94.651 or $1 (as of March 28, 2026 at 3:38 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹946.51 in Maxcyte Inc stock (as per the Rupee-Dollar exchange rate as on March 28, 2026 at 3:38 pm IST). Based on Maxcyte Inc share’s latest price of $0.68 as on March 28, 2026 at 1:29 am IST, you will get 14.7059 shares of Maxcyte Inc. Learn more about fractional shares .